Study: Parkinson's drug warnings ignored

Share this article:
More than half of U.S. Parkinson's disease patients are taking antipsychotic medications, despite U.S. Food and Drug Administration warnings that the practice could pose a risk of harm, a new study finds.

In 2005, the FDA started requiring that antipsychotic medications carry black box warnings saying that the drugs could pose risks to people with Parkinson's disease. Antipsychotics have been shown to worsen symptoms of dementia and psychosis in Parkinson's patients.

In analyzing Veterans Affairs data collected between 2002 and 2008, University of Pennsylvania researchers studied Parkinson's patients with dementia, Parkinson's and patients without dementia, and patients with dementia and psychosis but no Parkinson's disease.

They found that roughly half of the patients with Parkinson's disease and psychosis received an antipsychotic drug prescription, and that use of the drugs was higher in patients with both Parkinson's disease and dementia than among those without dementia.

The study was published in the July issue of the Archives of Neurology.
Share this article:

More in News

House bill would define, promote coordinated long-term care services

A bill introduced in the House of Representatives would target improved care coordination for seniors, also adding it under the Older Americans Act.

Skilled nursing facility trends contribute to improved Medicare outlook, Congressional report says

The Medicare trust fund is on track to remain solvent until 2030, trustees of the program stated in a Congressional report released Monday. This improved outlook is due in part to revised expectations about the case mix in skilled nursing facilities.

Seize the day: Tech Awards deadline is tomorrow

Seize the day: Tech Awards deadline is tomorrow

The final countdown has begun: Long-term care providers have less than 48 hours to enter the third annual McKnight's Excellence in Technology Awards. Submissions will be accepted through July 30.